Classer les publications sur l'année
-
Ăconomie de la santĂ©
Lifetime costs and effectiveness of ReSTOR compared with a monofocal IOL and Array-SA40 in the Netherlands
DE VRIES NE, LAURENDEAU C, LAFUMA A, BERDEAUX G, NUIJTS RM
Eye ; 2010;24(4):663-672
-
Ăconomie de la santĂ©
Inpatient costs of endophthalmitis evaluated for the whole of France
COLIN X, BERDEAUX G, LAFUMA A, SALVANET-BOUCHARA A, KODJIKIAN L
Appl Health Econ Health Policy ; 2010;8(1):53-60
-
Ăconomie de la santĂ©
In-patient care costs of patients with bipolar I disorder : a comparison between two European centers
GONZALEZ-PINTO AM, DARDENNES R, DE ZELICOURT M, LOPEZ P, OLIVEROS RG, VIETA E, BARBEITO S, ECHEVARRIA E, FAGNANI F
J Affect Disord ; 2010;121(1-2):152-155
-
Pharmaco-Epidémiologie
Infliximab Paediatric Crohn’s Disease Educational Plan : A European, Cross-Sectional, Multicentre Evaluation
ARANA A, ALLEN S, BURKOWITZ J, FANTONI V, GHATNEKAR O, RICO MT, VANHAVERBEKE N, WENTWORTH CE, BROSA M, ARELLANO F
Drug Saf ; 2010;33(6):489-501
-
Santé publique
Evaluation de réseaux de santé en diabétologie
DETOURNAY B, BOUEE S, DONIO V, GADENNE S, COUROUVE L
Qual Saf Health Care ; 2010;19(1):161-162
-
Efficacy of moxifloxacin in treating bacterial conjunctivitis : a meta-analysis
KODJIKIAN L, LAFUMA A, KHOSHNOOD B, LAURENDEAU C, BERDEAUX G
J Fr Ophtalmol ; 2010;33(4):227-233
-
Pharmaco-Epidémiologie
DiabĂšte de type 2 : pratiques d’intensification thĂ©rapeutique chez les mĂ©decins gĂ©nĂ©ralistes en France en 2008-2009
BOUEE S, DETOURNAY B, BALKAU B, BLICKE JF, AVIGNON A, ATTALI C, HALIMI S
BEH ; 2010;42-43:436-440
-
Pharmaco-Epidémiologie
Characteristics and management of outpatients with history of or current atrial fibrillation : the observational French EPHA study
COHEN A, DALLONGEVILLE J, DURAND-ZALESKI I, BOUĂE S, LE HEUZEY JY, the EPHA Investigators
Arch Cardiovasc Dis ; 2010;103(6-7):376-387
-
Ăconomie de la santĂ©
Analyse économique des soins des personnes traitées pour diabÚte (études Entred 2001 et 2007)
RICCI P, CHANTRY M, DETOURNAY B, POUTIGNAT N, KUSNIK-JOINVILLE O, RAIMOND V, THAMMAVONG N, WEILL A
Pratiques et Organisation des soins ; 2010;41(1):1-10
-
Ăconomie de la santĂ©
Treatment persistence and cost-effectiveness of latanoprost/latanoprost-timolol,bimatoprost/bimatoprost-timolol, and travoprost/travoprost-timolol in glaucoma : an analysis based on the United Kingdom general practitioner research database
LAFUMA A, SALMON JF, ROBERT J, BERDEAUX G
Clin Ophtalmol ; 2011;5:361-370
-
Ăconomie de la santĂ©
Management of relapsed or refractory multiple myeloma in French hospitals and estimation of associated direct costs: a multi-centre retrospective cohort study
ARMOIRY X, FAGNANI F, BENBOUBKER L, FACON T, FERMAND JP, HULIN C, MOREAU P, AULAGNER G
J Clin Pharm Ther ; 2011;36(1):19-26
-
Ăconomie de la santĂ©
Le coĂ»t de l’asthme en France et les implications Ă©conomiques de son niveau de contĂŽle
GADENNE S, PRIBIL C, CHOUAID C, VERGNENEGRE A, DETOURNAY B
Rev Mal Respir ; 2011;28(4):419-426
-
Pharmaco-Epidémiologie
Instauration de l’insulinothĂ©rapie chez les diabĂ©tiques de type 2 en France : donnĂ©es de l’Ă©tude INSTIGATE
CHARLES MA, CHARTIER F, BONNARD C, SMITH H, FAGNANI F, SALAUN-MARTIN C
MĂ©decine des Maladies MĂ©taboliques ; 2011;5(2):189-198
-
Pharmaco-Epidémiologie
Five-year extension of a clinical trial comparing the EX-PRESS glaucoma filtration device and trabeculectomy in primary open-angle glaucoma
DE JONG L, LAFUMA A, AGUADE AS, BERDEAUX G
Clin Ophtalmol ; 2011;5:527-533
-
Epidemiology of atrial fibrillation in France : extrapolation of international epidemiological data to France and analysis of french hospitalization data
CHARLEMAGNE A, BLACHER J, COHEN A, COLLET JP, DIEVART F, DE GROOTE P, HANON O, LEENARDT A, PINEL JF, PISICA-DONOSE G, LE HEUZEY JY
Arch Cardiovasc Dis ; 2011;104:115-124
  Â